How are Trump's tariffs impacting US companies?
Why are Rivian's delivery forecasts being cut?
What caused recent delays at Newark Airport?
How did DoorDash's acquisition affect its market share?
Why is AMD's data center revenue surging?
What are the implications of the UK-India trade deal?
How did Meta win damages from spyware vendor NSO?
Why is Mattel increasing toy prices?
What is driving Tesla's sales decline in Europe?
Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
benzinga.com/25/05/45231488/neurocrine-biosciences-ingrezza-q1-sales-more-resilient-than-investors-feared-analysts-boost-price-target
Neurocrine Biosciences Inc. (NASDAQ:NBIX) stock is trading higher on Tuesday after the company reported better-than-expected first-quarter 2025 earnings.
The company on Monday reported adjusted EPS of 70 cents, lower than the $1.20 reported a year ago, beating the consensus of 54…
This story appeared on benzinga.com, 2025-05-06 17:24:29.